Design, synthesis and biological evaluation of novel 7-azaspiro[3.5]nonane derivatives as GPR119 agonists

Add time:07/11/2019    Source:sciencedirect.com

The design and synthesis of a novel class of 7-azaspiro[3.5]nonane GPR119 agonists are described. In this series, optimization of the right piperidine N-capping group (R2) and the left aryl group (R3) led to the identification of compound 54g as a potent GPR119 agonist. Compound 54g showed a desirable PK profile in Sprague-Dawley (SD) rats and a favorable glucose lowering effect in diabetic rats.

We also recommend Trading Suppliers and Manufacturers of 3-[2-(p-Fluorophenoxy)ethyl]-3-azaspiro[5.5]undecane (cas 1228-30-4). Pls Click Website Link as below: cas 1228-30-4 suppliers

Prev:Facile synthesis and spectral characterization of 2, 5-bis (cyclohexylamino)-1, 4-benzoquinone polymorphs from methyl and ethyl protocatechuic aldehydes
Next:Thermodynamics of 4’-bromomethyl-2-cyanobiphenyl in different solvents)